Cargando…
A Descriptive Study on Opioid Misuse Prevalence and Office-Based Buprenorphine Access in Ohio Prior to the Removal of the Drug Addiction Treatment Act of 2000 Waiver
Background Medications for the treatment of opioid use disorder (MOUD) are effective evidence-based strategies to reduce opioid overdose deaths. Strategies to optimize MOUD availability and uptake are needed. Objective We aim to describe the spatial relationship between the estimated prevalence of o...
Autores principales: | McKnight, Erin R, Dong, Qianyu, Brook, Daniel L, Hepler, Staci A, Kline, David M, Bonny, Andrea E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151104/ https://www.ncbi.nlm.nih.gov/pubmed/37139287 http://dx.doi.org/10.7759/cureus.36903 |
Ejemplares similares
-
Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver
por: Lanham, Holly J., et al.
Publicado: (2022) -
The Relationship Between Hepatitis C Virus Rates and Office-Based Buprenorphine Access in Ohio
por: Brook, Daniel L, et al.
Publicado: (2021) -
1053. The Ecological Relationship Between County-Level HCV Case Rates and Office-Based Buprenorphine in Ohio
por: Brook, Daniel L, et al.
Publicado: (2020) -
Access to and Payment for Office-Based Buprenorphine Treatment in Ohio
por: Parran, Theodore V, et al.
Publicado: (2017) -
Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022)